Pleural effusions (PE) reportedly occur most commonly secondary to bacterial pneumonia with neoplastic effusions contributing a minority of cases. The majority of reports originate from the USA and Australia, where long distance transport of horses, a recognised risk factor, may occur more frequently than in the UK. Anecdotally, a greater proportion of horses with PE are diagnosed with neoplasia in the UK than has been reported. The aim of this retrospective study was to describe the causes of PE in horses in the UK, and to identify markers that can help differentiate between septic and neoplastic causes of PE. Medical records from 4 equine hospitals in the UK were searched for horses diagnosed with PE. Information recorded included case background, admission physical examination and biochemical findings, and characteristics of the effusion (volume, cell count, total protein [TP] concentration). A total of 69 horses were identified, with 26 (38%) diagnosed with a neoplastic effusion. The remainder were categorised as septic, including 14/43 (32.5%) that had a history of international transport. Horses with septic effusions were significantly younger (8 vs. 13 years; P = 0.001) and had significantly smaller volumes of pleural fluid drained at admission (9.8 l vs. 32.2 l; P<0.001). Horses with septic PE had a significantly higher rectal temperature (38.6°C vs. 38.2°C; P = 0.03), fibrinogen concentration (7.8 g/l vs. 5.3 g/l; P = 0.01) and serum amyloid A concentration (230 mg/l vs. 59 mg/l; P = 0.02) than those with neoplastic effusions. Significantly higher pleural fluid cell count and TP concentration were identified in horses with septic PE (63.9 3 10 9 /l vs. 8.6 3 10 9 /l; P<0.001; 57.5 g/l vs. 35.9 g/l; P = 0.04). These results suggest that in the UK, neoplastic effusions account for a greater proportion of PE than previously reported. A large volume of PE in an older horse with a low cell count and relatively low TP concentration should increase the index of suspicion of neoplasia.
Introduction
The majority of cases of pleural effusion reported in the scientific literature describe horses with septic pleuropneumonia, resulting from extension of bacterial infection of the lungs into the pleural cavity, and most of these studies originate from the USA or Australia (Smith 1977; Raphel and Beech 1982; Sweeney 1992; Collins et al. 1994; Austin et al. 1995; Arroyo et al. 2015) . In the UK, however, a greater proportion of pleural effusion cases seem to be caused by neoplasia, although the evidence to support this is scarce (Mair et al. 2004; Mair 2012) . Early determination of the cause of a pleural effusion is paramount, so that prompt and appropriate treatment can be instigated in cases amenable to treatment, or euthanasia be performed in cases with a hopeless prognosis. The aim of this study was thus to determine whether horses identified with pleural effusion and resident in the UK are more frequently diagnosed with neoplasia than has been reported in previous studies, and to determine whether factors present at admission could be used to increase the index of suspicion for a neoplastic pleural effusion.
Methods
Records of horses presented to 4 equine referral hospitals in the UK between 2000 and 2014 were searched for horses in which a pleural effusion had been diagnosed. The cause of the effusion was then categorised as either neoplastic, septic or 'other' based on information in the medical records including history, analysis of pleural fluid and tracheal wash characteristics, ultrasonographic and radiographic findings, and post mortem results as applicable. A history of travel prior to the development of clinical signs was recorded, as was admission clinical and clinicopathological data, and outcome. Outcome was recorded as survival to discharge. Clinical data recorded included case history, admission heart rate, respiratory rate and rectal temperature, clinical signs and duration of those signs prior to admission, and volume of pleural fluid drained at admission. Clinicopathological data included admission packed cell volume, total plasma protein concentration, serum amyloid A and fibrinogen concentrations, pleural fluid nucleated cell count (NCC) and total protein concentration, results of cytological examination of pleural fluid, and bacterial culture results of tracheal wash samples, pleural fluid or both. When a sample was obtained from both sides of the thorax, the mean protein and nucleated cell count was used for statistical comparisons. Normality of continuous data was assessed utilising the KolmogorovSmirnov statistic, and differences between categories compared as appropriate. No cases of pleural effusion due to 'other' reasons were identified and thus differences between septic and neoplastic pleural effusions were compared using either the independent t test or the Mann Whitney U test. For all tests, the null hypothesis was rejected when P<0.05.
Results
A total of 69 horses with pleural effusions was identified. Not all data were available for all horses. The horses ranged in age from 1-28 years (n = 56; median 10.5 years, interquartile range 10 years) and included a variety of breeds, with the largest single group being Thoroughbreds or Thoroughbred crosses (24/65; 38%). There were 33 geldings, 23 mares and 5 intact males. Clinical signs present at admission were recorded for the majority of horses, and were similar for horses with either neoplasia or septic causes of effusion. The most common signs included increased respiratory rate (>15 breaths/min) and/or effort (59/64), tachycardia (heart rate >44 beats/min; 56/64), depressed mentation (42/59), nasal discharge (27/59), lethargy (21/59), pyrexia (>38.5°C; 31/62), cough (15/59) and weight loss (15/59). Peripheral masses or lymphadenopathy were only identified in 2 horses. The duration of clinical signs was recorded in 40 horses, and ranged from 1 day to 6 months (median 7 days).
A diagnosis of neoplasia was made in 26/69 (38%) of horses. A definitive diagnosis was made in 23 of these; the diagnosis was made in 12 horses at post mortem examination and in 11 via cytological analysis of pleural fluid. In an additional 3 horses, a presumptive diagnosis of neoplasia was made. In one of these 3 horses, thoracic radiographs revealed multifocal rounded radiodense lesions throughout the lungs and the mediastinum, although cytological or histological confirmation was not pursued. In the second, a mediastinal mass was identified via ultrasonography, and in the third, masses within the kidney and pelvic cavity were identified via ultrasonography, in addition to 2 masses within the lungs evident on thoracic radiographs. Lymphoma was diagnosed in 11 horses, unspecified carcinoma in 3, mesothelioma in 3, melanoma in 2 and for 7 horses a specific type of neoplasia was not confirmed.
Forty-three horses were diagnosed with pleural effusions caused by septic causes. Within this category, 17/43 (39.5%) had a history of international travel; 5 horses had travelled from Ireland to the UK, 5 from mainland Europe to the UK, 3 from Argentina to the UK, one from New Zealand to the UK. In an additional 3 horses, a history of travel was documented but no details provided as to the duration or distance. For horses with no history of travel, other risk factors identified included general anaesthesia (n = 1) and oesophageal disorders (intraluminal obstruction n = 2; extraluminal compressive mass n = 1; oesophageal rupture n = 2). Table 1 shows admission clinical and clinicopathological findings. Horses with neoplastic effusions were significantly older (median 13 years vs. 8 years; P = 0.001), had a significantly lower rectal temperature (mean 38.2°C vs. 38.6°C; P = 0.04), and lower acute phase protein concentrations (serum amyloid A: median 59 mg/l vs. 230 mg/l, P = 0.02; fibrinogen mean: 5.3 g/l vs. 7.8 g/l, P = 0.01) vs. horses with septic pleural effusions. No significant differences in heart rate, respiratory rate, packed cell volume or total plasma protein concentration were identified between horses with neoplastic vs. septic effusions.
Pleural fluid analysis was performed in 48 horses. The NCC and total protein concentration of the pleural fluid were both significantly lower in horses with neoplastic effusions compared to septic effusions (median NCC 8.6 AE 15.3 9 10 9 /l vs. 63.9 AE 68 9 10 9 /l; P<0.001; median total protein concentration 35.9 AE 16.9 g/l vs. 57.5 AE 43 g/l; P = 0.04). The mean volume of pleural fluid drained at admission was significantly greater in horses with neoplasia (32.2 AE 17.9 l) than those with septic effusions (9.8 AE 7.6 l; P<0.001).
Bacterial culture of either tracheal wash samples, pleural fluid aspirates or both was performed in 34 cases with a final diagnosis of septic pleural effusion. No growth was obtained in 6/34 (17.6%), a single isolate was obtained in 10/34 cases (29%) and a mixed bacterial population in 18/34 (52.9%). The most common isolates were Streptococcus spp. (n = 16), Escherichia coli (n = 12), Enterococcus faecalis (n = 6) and anaerobes (n = 6; including 3 Bacteroides spp., 2 Fusobacterium necrophorum and one Clostridium perfringens). Other isolates included Actinobacillus spp., Corynebacterium spp. and Klebsiella spp. (all single isolates).
Details of diagnostic imaging results, including radiographic and ultrasonographic findings, were not recorded in sufficient detail in most cases to allow for meaningful analysis. For example, the presence or absence of pleural fluid on ultrasonographic examination was noted, but characterisation of pulmonary parenchymal changes, fibrin accumulation or presence of gas bubbles within pleural fluid was not consistently reported.
Outcome was recorded as survival to discharge. Overall, there were 43 nonsurvivors, 24 survivors and 2 horses in which outcome was not recorded. For horses with septic pleural effusions, survival rate was 47.6% (20/42). All horses with septic pleural effusions secondary to an oesophageal disorder died or were subjected to euthanasia. Six horses with neoplastic effusions were discharged from the hospital, presumably for either palliative treatment or euthanasia at home, although this was not recorded.
Discussion
The findings of this study support the clinical impression that in the UK, pleural effusions secondary to neoplasia occur relatively more frequently than has been previously described in reports from other countries. Although direct comparisons (Smith 1977) . A second study, also from the USA, identified 32/122 (26%) of horses with effusion caused by 'noninfectious' causes, although these were not further categorised (Raphel and Beech 1982) . Long distance transport is a recognised risk factor for the development of pleuropneumonia and septic pleural effusion (Raphel and Beech 1982; Austin et al. 1995) . Head elevation during transportation minimises a horse's ability to clear lower respiratory tract (LRT) secretions and inhaled bacteria (Norton et al. 2013) . Combined with the physiological stress associated with travelling, the defence mechanisms of the LRT such as mucociliary transport, pulmonary alveolar macrophages and neutrophils can become overwhelmed (Oikawa et al. 1995; Smith et al. 1996; Norton et al. 2013) . Establishment of infection within the lungs results in increased capillary permeability of the inflamed lung and visceral pleura, resulting in the accumulation of a sterile transudate within the pleural cavity. Bacteria from the infected lung rapidly invade the pleural space, resulting in the accumulation of a large volume of fluid packed with inflammatory cells, cellular debris and bacteria (Oikawa et al. 1995; Reuss and Gigu ere 2015) . Most studies define long distance transport as over 500 miles, and, as such, it is possible that the relatively short distances that horses travel within the UK, as compared to countries such as the USA and Australia, may contribute to the lower proportion of septic pleural effusions. Interestingly, in the current study, 40.5% of horses with septic pleural effusions had a history of long distance travel (in 14/17, known international transport) in comparison to 24.4% reported by Raphel and Beech (1982) . Thus, long distance transport is a consistent risk factor for the development of pleuropneumonia, regardless of geographic location. In this study, horses with neoplasia were significantly older than those with septic pleural effusions. Horses with pleuropneumonia are typically young, with mean ages of 3.6 years and 2.5 years in 2 studies (Collins et al. 1994; Arroyo et al. 2015) . Presumably, this is associated with an increased likelihood for younger horses to be transported long distances for competitive reasons, or to undertake high intensity exercise. In the current study, horses with septic pleural effusions were older than in other reports with a median age of 8 years, suggesting that age in itself may not be a specific risk factor, more that factors that increase the risk of developing septic pleural effusions are more likely to occur in younger horses. Whilst horses with neoplasia were older than those with septic pleural effusions in the current study, neoplasia can affect any age of horse (Taintor and Schleis 2011) . Lymphoma is typically identified in horses aged 4-10 years, with a mean age of 7 years in one study (Mair et al. 1985; Taintor and Schleis 2011) . As such, although there was a statistically significant difference between the age of both groups, young age in itself should not be relied on to rule out neoplasia as a cause of pleural effusion.
Consistent with previous reports, neoplasia in this study was associated with large volume accumulation of pleural fluid, with up to 55 l drained in several horses (Fig 1) (Mair et al. 1985 (Mair et al. , 2004 . The development of such large volume effusions is presumed to occur due to decreased lymphatic drainage, especially when mediastinal masses are present, and/or to increased fluid production, when the neoplasm affects the pleural surfaces (DeHeer et al. 2002; Mair et al. 2004) . In most horses with neoplasia in the current report, the pleural fluid was described as a modified transudate, with a relatively low NCC and moderately increased total protein concentration. As would be expected, both the NCC and the total protein concentration were significantly higher in horses with septic causes of pleural effusion.
A definitive diagnosis of neoplasia can be made if cytological evaluation of the fluid identifies neoplastic cells or if masses are accessible for biopsy (Figs 2 and 3 ) (Sweeney and Gillette 1989; Mair et al. 2004) . Lymphoma is believed commonly to result in exfoliation of neoplastic cells into the pleural fluid and in 2 reports up to 40% of cases were diagnosed ante mortem via cytological analysis of pleural fluid (Mair et al. 2004; Lee et al. 2013) . Similarly, in the current study, a diagnosis of neoplasia was made in 38% of horses via cytological examination of pleural fluid. As has Causes of pleural effusions in horses been previously described, most cases in the current series did not present with a peripheral lymphadenopathy or visible mass that would be amenable to biopsy for histological analysis (Mair et al. 2004) . A recent report described biopsy of intrathoracic masses in 2 horses via thoracoscopy, allowing the authors to confirm a diagnosis of neoplasia in each case, suggesting that in selected cases, this may be an appropriate and effective diagnostic tool (Lee et al. 2013) .
The prognosis for horses with septic pleural effusion in the current series was relatively poor, with only 47% of horses surviving to discharge. From the records available, it was not possible to determine whether horses were subjected to euthanasia due to poor prognosis and failure to respond to treatment, or whether euthanasia was elected for financial reasons. Previous reports have similarly identified overall survival rates of approximately 50% although more recent reports suggest that with early identification and treatment, outcomes can be much improved (Arroyo et al. 2015; Tomlinson et al. 2015) . Factors associated with failure to survive in previous studies have included infection caused by anaerobic bacteria, a larger volume of pleural fluid and the presence of fibrinous effusions (Figs 4 and 5) (Sweeney et al. 1991; Tomlinson et al. 2015) . Anaerobic bacteria were only identified in 6 horses in the current study, making correlations between their presence and survival difficult to interpret. Consistency in reporting fibrinous effusions precluded analysis of this characteristic. Pleural fluid drainage (as compared to thoracocentesis for sampling) was only performed in 13 horses with septic PE; although not recorded, it may be that, in the remaining horses, the volume of effusion did not warrant drainage, although this is a presumption, as accurate measurements of ultrasonographic dimensions of visible pleural fluid were not recorded in most cases. In the current report, all cases with septic effusions secondary to oesophageal disorders did not survive. Two horses developed aspiration pneumonia secondary to oesophageal obstruction, 2 developed oesophageal rupture of unknown cause, and one had an extraluminal mass compressing the oesophagus, resulting in aspiration. Five cases of intrathoracic oesophageal perforations with resultant septic pleural effusions have recently been reported, all with a similarly grave outcome (Hepworth-Warren et al. 2015) . Aspiration of feed material and subsequent pneumonia following oesophageal obstruction was not reported in 60 horses treated in a primary care setting (Duncanson 2006) . In comparison, 8/34 horses presented to a referral hospital developed pneumonia, which was significantly associated with duration of clinical signs (Feige et al. 2000) . Interestingly, the degree of feed material contamination of the trachea (assessed endoscopically) was not associated with the development of pneumonia, suggesting that this may not be a sensitive tool in the assessment of whether aspiration has occurred or not. Considering the poor outcome in horses with oesophageal disorders, close monitoring of animals with oesophageal obstruction, and prompt evaluation and treatment of those suspected of having aspiration is warranted (Feige et al. 2000) .
This study is limited by its retrospective nature; not all data were available for all horses. A definitive diagnosis of the type of neoplasia was not obtained in all horses, making a more detailed assessment of characteristics of individual tumour types impossible. Survival was based solely on survival to hospital discharge, which is likely to have skewed the data as several horses with neoplasia were classified as survivors due to the fact that they went home, presumably for euthanasia or palliative therapy. Although successful treatment of thoracic neoplasia has been reported, the prognosis is still considered hopeless (Mair et al. 2004; Saulez et al. 2004) . Pleural effusions can develop for a number of reasons, the two most common being pleuropneumonia (septic) and neoplasia. In this study, horses with septic pleural effusions were younger than those with neoplasia, had significantly higher acute phase protein concentrations at admission, and had a smaller volume of pleural effusion with a higher NCC and total protein concentration. Of the 26 horses with confirmed or suspected neoplasia, the diagnosis was confirmed at post mortem examination in 12 horses, although in some cases a high index of suspicion existed without confirmation via cytological analysis of pleural fluid or lymph node aspirate. In 11 horses, a diagnosis was made ante mortem using cytological analysis of pleural fluid, and, in 3 horses, masses evident on ultrasound or radiography were consistent with neoplasia but cytological confirmation was not pursued. This information may be helpful in making a prompt diagnosis when the clinician is presented with a horse with pleural effusion.
